News
EKTAY
5.74
NaN%
--
Elekta price target lowered to SEK 52 from SEK 61 at JPMorgan
TipRanks · 12/08 17:21
These Healthcare Stocks Just Exploded In Momentum — Investors Are Taking Notice
Benzinga · 12/03 20:57
Elekta AB Earnings Call: Growth Amid Challenges
TipRanks · 11/28 00:04
Elekta AB Reports Strategic Reset and Financial Highlights
TipRanks · 11/27 03:57
Elekta AB reports Q2 results
Seeking Alpha · 11/26 13:07
Elekta AB Non-GAAP EPS of SEK 0.64, revenue of SEK 4.07B; reaffirms FY outlook
Seeking Alpha · 11/26 12:24
Elekta AB (0O5H) Gets a Sell from Barclays
TipRanks · 11/25 01:25
Accuray's Latest Transformation Attempt Could Be Too Little Too Late
Seeking Alpha · 11/06 17:35
Barclays Sticks to Their Sell Rating for Elekta AB (0O5H)
TipRanks · 10/29 01:25
EU MedTech stocks down as U.S. launches national security probe into imports
Seeking Alpha · 09/25 11:06
Weekly Report: what happened at EKTAY last week (0908-0912)?
Weekly Report · 09/15 10:35
Weekly Report: what happened at EKTAY last week (0901-0905)?
Weekly Report · 09/08 10:37
Elekta initiated with a Sell at UBS
TipRanks · 09/03 08:35
UBS Initiates a Sell Rating on Elekta AB (0O5H)
TipRanks · 09/03 08:15
Weekly Report: what happened at EKTAY last week (0825-0829)?
Weekly Report · 09/01 10:33
Elekta AB (0O5H) Receives a Hold from Deutsche Bank
TipRanks · 09/01 10:05
Kepler Capital Reaffirms Their Hold Rating on Elekta AB (0O5H)
TipRanks · 08/30 01:46
Elekta price target lowered to SEK 48 from SEK 49.50 at Barclays
TipRanks · 08/29 17:45
Goldman Sachs Sticks to Its Sell Rating for Elekta AB (0O5H)
TipRanks · 08/29 12:55
Barclays Sticks to Their Sell Rating for Elekta AB (0O5H)
TipRanks · 08/29 09:35
More
Webull provides a variety of real-time EKTAY stock news. You can receive the latest news about Elekta Ab through multiple platforms. This information may help you make smarter investment decisions.
About EKTAY
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.